Seoul Pharma Co. Ltd. (KOSDAQ:A018680) announced a private placement of second unregistered unsecured private convertible bonds for gross proceeds of KRW 20,000,000,000 on April 8, 2016. The convertible bonds carry fixed 2% yield to maturity and zero coupon rate, lump-sum redemption of principal on maturity date for the bonds.

The convertible bonds will be converted at fixed conversion price of KRW 14,100 per share and the conversion period is from May 28, 2016 to March 28, 2019. The convertible bonds will mature on April 28, 2019.